CASZ1 and cancer: First, the GSEA analysis revealed that CASZ1 overexpression was related to cancer‐related signaling pathways, including the “Notch signaling,” “transforming growth factor‐beta (TGF‐β) signaling,” “IL6_JAK_STAT3 signaling,” and “EMT signaling” (Figure 4B).